Devrim Çabuk

13PUBLICATIONS
106CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsiesPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 24, 2026
Real-World Outcomes of Second-Line Chemotherapy in Metastatic Urothelial Carcinoma.

|Jun 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|May 08, 2026
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.

|Apr 14, 2026
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab.

Gözde Ağdaş, Duygu Bayir, Elif Şahin

|Mar 28, 2026
EASIX Score as an Independent Prognostic Marker in De Novo Metastatic Pancreatic Cancer.

İlkay Çıtakkul, Yasemin Bakkal Temi, Zehra Aytin

|Mar 14, 2026
The Pretreatment Glucose-to-Lymphocyte Ratio as an Independent Prognostic Biomarker in Ovarian Cancer.

Ece Baydar, Yasemin Bakkal Temi, İlkay Çıtakkul

Pageof 3

Frequent Collaborators

7 joint publications

Elif Sahin

6 joint publications

Umut Kefeli

5 joint publications

Nargiz Majidova

5 joint publications

Deniz Can Guven